+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Dyslipidemia - Pipeline Insight, 2025 - Product Thumbnail Image

Dyslipidemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Early Cardiogenic Shock (CS) - Pipeline Insight, 2025 - Product Thumbnail Image

Early Cardiogenic Shock (CS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Erosive Hand Osteoarthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Erosive Hand Osteoarthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Eye Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Eye Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Eye Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Eye Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gaucher's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Glaucoma - Pipeline Insight, 2025 - Product Thumbnail Image

Glaucoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 170 Pages
  • Global
From
Infantile Spasm - Pipeline Insight, 2025 - Product Thumbnail Image

Infantile Spasm - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2025 - Product Thumbnail Image

No Option Refractory Disabling Angina (NORDA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nocturnal Enuresis - Pipeline Insight, 2025 - Product Thumbnail Image

Nocturnal Enuresis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Obstructive Sleep Apnea (OSA) - Pipeline Insight, 2025 - Product Thumbnail Image

Obstructive Sleep Apnea (OSA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Ophthalmoplegia - Pipeline Insight, 2025 - Product Thumbnail Image

Ophthalmoplegia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Osteogenesis Imperfecta (OI) - Pipeline Insight, 2025 - Product Thumbnail Image

Osteogenesis Imperfecta (OI) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Paget's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Paget's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Parkinson's Disease Psychosis - Pipeline Insight, 2025, - Product Thumbnail Image

Parkinson's Disease Psychosis - Pipeline Insight, 2025,

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Paroxysmal Hemoglobinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Paroxysmal Hemoglobinuria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more